Abstract: Recently, we demonstrated that plasma aldosterone contributed to insulin resistance in chronic kidney disease. The aim of this study is the clinical impact of this relationship in hemodialysis patients. In a cross section study using a total of 128 hemodialysis patients, multiple regression analysis revealed that plasma aldosterone levels were independently associated with HOMA-IR, insulin resistance index. This association was found to be more stringent in diabetic patients than in non-diabetic patients. Aldosterone levels were associated with cardiac hypertrophy and carotid artery stenosis. HOMA-IR was associated with cardiac hypertrophy. The patients whose aldosterone and HOMA-IR were above the top tertile of each parameter in this cohort showed more severe cardiac hypertrophy and lower contractile function as compared with the patients whose aldosterone levels and HOMA-IR are below the lowest tertile of each parameter. In conclusion, in hemodialysis patients, aldosterone levels and insulin resistance are closely interrelated and the constellation of the two is related to severe cardiovascular tissue damages.
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Patients with end-stage renal disease (ESRD), especially those on dialysis, are complicated by various cardiovascular complications, which affect patients' mortality and morbidity. Several factors are associated with the pathogenesis of the cardiovascular events in these patients, including volume overload, cardiac remodeling, abnormal vascular remodeling, and vascular calcification. The underlying mechanisms for these abnormal changes of cardiovascular tissues comprise mineral disorders or hormonal disorders, such as hyperphosphatemia or hyperparathyroidism (1) .
Among these hormonal disorders, hyperaldosteronism is considered to play an important role (1) . In patients with ESRD, plasma aldosterone levels are higher than those in normal subjects (2) presumably due to high potassium levels or a decrease in urinary clearance (3) . This increase might be responsible for the higher incidence of cardiovascular events in patients on dialysis because a recent study showed that blockade of the aldosterone receptor, mineralocorticoid receptor (MR), reduced the risk of cardiovascular events in a randomized, prospective, clinical trial (4) .
Another hormonal dysregulation in patients with ESRD is insulin resistance, which is defined as an increase in insulin levels in relation to any plasma glucose level (5) . Insulin resistance is clinically diagnosed by the glucose clamp method, or more practically, by assessing the homeostasis model of insulin resistance index (HOMA-IR). Insulin resistance is often found in patients with obesity or type II diabetes as well as with chronic kidney disease (CKD), which is related to cardiovascular events (6) . A previous study reported that patients with renal dysfunction showed insulin resistance, even with mild to moderate levels of renal dysfunction and that insulin resistance was related to a higher risk of cardiovascular events (6) . However, the morbidity or clinical relevance of insulin resistance in patients on dialysis has not been fully determined. To evaluate insulin resistance in clinical practice the gold standard is euglycemic glucose clamp technique which is far too labor intensive. For this reason, several more practical methods, such as homeostatic model assessment of insulin resistance (HOMA-IR) (7) , the quantitative insulin sensitivity check index (QUICK) (8) , and McAuley's index (8) , are widely used in several recent studies. In one study in hemodialysis patients, the association of HOMA-IR index with the gold standard hyperinsulinemic euglycemic clamp has been examined, which suggested that HOMA-IR is not the best available index but reasonable index to estimate insulin resistance (8) . This convenient index is still used in studies examining the role of insulin resistance or hyperinsulinemia in tissue damages in hemodialysis patients and has uncovered some important clinical aspects of hemodialysis patients (9, 10) .
We recently reported that in non-dialytic patients with CKD insulin resistance was observed, the severity of which was correlated with the degree of renal dysfunction. We also demonstrated that insulin resistance was closely related to plasma aldosterone levels (11) . Intervention with aldosterone receptor blockade using spironolactone ameliorated insulin resistance in CKD, which suggested a causal link between these two important cardiovascular risk factors (11) . In the present study, we examine the relationship between plasma aldosterone levels and the HOMA-IR in patients on maintenance hemodialysis (HD). We also delineate that the association of several cardiovascular functional parameters with aldosterone or HOMA-IR.
PATIENTS AND METHODS

Patients
We performed a cross-sectional study that was composed of patients receiving HD at Kawashima Hospital in Sako-cho, Tokushima by July 2016. Inclusion criteria were an age of 20 years or older and a duration of previous dialysis for 6 months or longer. We excluded the following patients from the study: patients who suffered from active malignancy or severe infection, and those who did not consent to be included in this study. The study comprised 128 patients (95 men; 68.9 AE 10.5 years old; range, 34-89 years old). No patients were obese (body mass index [BMI], 21.9 AE 3.0 kg/m 2 ; range, 18-29), and none were malnourished. Fourty-nine patients (38.2%) were diabetic. Their mean HbA1c level was 6.4% (5.0-9.3%) and mean glycosylated albumin level was 18.8% (11.7-30.6%). Hemodialysis was performed three times a week (4 h per session), with an average blood flow rate of 150 to 250 mL/ min and dialysate flow of 500 mL/min. Mean Kt/V was maintained at 1.2 or higher during the study.
The study protocol was approved by the local scientific ethics committee at Kawashima Hospital. Each patient provided informed consent.
Demographic variables, including age, sex, comorbidity, duration of HD, and anthropometric measurements, were recorded. After an overnight fast at the beginning of the week, pre-dialysis blood samples were drawn for analysis of laboratory values. Nursing staff measured systolic and diastolic blood pressure using standard sphygmomanometers in seated participants who had rested for at least 5 min. Weight and height were determined for each patient on the day when the patient undertook the blood test. BMI was calculated as weight in kilograms divided by the square of the height in meters.
Biochemical sampling and assays
Fasting blood samples were taken while patients were lying in bed in the supine position after at least 15 min of rest on the first dialysis day of the week. Various parameters were measured by conventional methods at an external testing laboratory. Parameters that were measured before dialysis were plasma levels of hemoglobin, iron, ferritin, total iron binding capacity, creatinine, blood urea nitrogen (BUN), β2-microglobulin, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), total protein (TP), albumin (Alb), total bilirubin, C-reactive protein, sodium, potassium (K), chloride, calcium, inorganic phosphorus (iP), intact parathyroid hormone, glycosylated albumin, uric acid (UA), aldosterone, asymmetrical dimethylarginine (ADMA), and homocysteine. We measured the white blood cell count (WBC), red blood cell count, platelet count (Plt), mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration and post-dialysis values of BUN and creatinine. We also measured plasma levels of alanine aminotransferase, aspartate aminotransferase, choline esterase (ChE), lactate dehydrogenase, creatinine phosphokinase, alkaline phosphatase, and γ-glutamyltransferase. Insulin sensitivity was evaluated with the HOMA-IR, which was calculated by plasma insulin (μU/L) × fasting plasma glucose (mg/dL) / 405 (12 (14) . Mean value for each biochemical parameter of this study group is shown in Table 1 .
Classification of patients according to plasma aldosterone levels and HOMA-IR
To identify patients with a high risk of cardiovascular events, we classified the patients according to plasma aldosterone levels and HOMA-IR. We defined the high risk population (HH group) as those whose aldosterone levels were higher than the top tertile level (200 pg/mL) and those whose HOMA-IR was higher than the top tertile level (1.3) (N = 17). We also defined patients with both aldosterone levels and HOMA-IR that were lower than the lowest tertile level (90 pg/mL and 0.9, respectively) as LL group (N = 20). Finally we defined all the other patients than those in HH group or in LL group as M group (N = 91). We compared various cardiovascular parameters among these three groups.
Echocardiography
Echocardiography was performed after hemodialysis using the Philips ie33 (Andover, MA, USA) ultrasound system equipped with a 2-to 7-MHz X7-2t TEE matrix transducer. Left ventricular systolic function was assessed by the left ventricular ejection fraction (EF). Left ventricular diastolic function was evaluated by the ratio of E to e-prime (E/e 0 ). Cardiac hypertrophy was assessed by the left ventricular mass index, interventricular septum thickness (IVST), posterior left ventricular wall thickness (PWT), and relative wall thickness (RWT). RWT was defined by 2 × PWT/left ventricular enddiastolic diameter. Mean value for each parameter of the study population is shown in Table 2 .
Carotid artery ultrasound
Carotid artery ultrasound examination of the common carotid artery, bulb, and internal carotid artery was performed bilaterally using the LOGIQ S8 (GE Healthcare, Wauwatosa, WI, USA). The carotid intima-media thickness (IMT) of the far wall was measured 10 mm proximal to bifurcation. The mean IMT (IMT-mean) was determined as the mean value of measured IMT and the largest IMT value was recorded as the maximum IMT (IMT-max). The mean values of IMT-mean and IMT-max of the left and right sides were used for analysis. Moreover, the higher values of IMT-mean and IMT-max between the left and right sides were used for analysis. We also measured the ED ratio, which was calculated as end-diastolic velocity of the non-affected side divided by that of the affected side. This ratio can identify internal carotid artery and middle cerebral artery occlusion (15) . Therefore, the higher the ED value, the more probable the presence of carotid artery stenosis. Mean value for each parameter of this study group is presented in Table 3 .
The ankle-brachial index and brachial-ankle pulse wave velocity
The values of the ankle-brachial index (ABI) and brachial-ankle pulse wave velocity (baPWV) were measured using the volume-plethysmographic apparatus PWV/ABI (Omron Healthcare Co., Ltd., Kyoto, Japan). The mean and higher baPWV values between the right and left side, defined as baPWV-mean and baPWV-higher, were used for analysis. The mean and the lower ABI values between the right and left sides, defined as ABI-mean and ABI-lower, were used for analysis. In analysis of baPWV, we excluded patients whose ABI was less than 0.9 because arterial occlusion may reduce baPWV and thus PWV value was assessed incorrectly. Mean value for each parameter of this study group is shown in Table 3 .
Calcified tissue score of the aorta
The presence and quantity of aortic calcium were evaluated as described previously (16) . The total aortic calcium score was determined by adding up each of the scores for all 20 slices of a computed tomographic (CT) scan. Images were obtained with a 320-row multislice CT scanner (320 CT; Aquilion ONE, Toshiba Medical Systems, Tokyo, Japan).
Statistical analyses
Correlations between each parameter were analyzed using simple regression and step-wise multiple regression analyses. Data are expressed as the mean AE SEM and P values less than 0.05 were considered statistically significant. For the comparison among the groups, data are expressed as mean AE SEM and analyzed by one-way analysis of variance (ANOVA), followed by the Fisher's post hoc test. A value of P < 0.05 was considered statistically significant. Statistical analyses were performed using STATVIEW J-4.5 statistical software (Abacus Concepts, Piscataway, NJ, USA).
RESULTS
Baseline characteristics of patients on hemodialysis
The characteristics of the patients in this study are shown in Table 1 . The mean age of the patients was 68.9 AE 10.6 years and 62.5% of the patients were men. The mean duration of hemodialysis was 9.3 AE 8.6 years and 38% of the patients were diabetic. The mean BMI was 21.8 AE 0.3 kg/m 2 and mean systolic blood pressure was 152 AE 29 mmHg. Mean values of pre-dialysis BUN levels, creatinine levels, β2-MG levels, Kt/V, and n-PCR were 55.4 AE 13.3 mg/dL, 10.5 AE 2.8 mg/dL, 1.61 AE 0.32, 26.08 AE 0.55 mg/L, and 0.81 AE 0.01 g/kg/day, respectively. Mean values of each parameter indicative of a cardiovascular risk factor, including plasma levels of aldosterone, homocysteine, and ADMA, and HOMA-IR were 350 AE 71 pg/mL, 38.8 AE 2.5 nmol/mL, 0.65 AE 0.14 nmol/L, and 0.65 AE 0.14, respectively. Mean values of each parameter of echocardiography are shown in Table 2 . Mean values of the parameters of vascular damage are shown in Table 3 .
Plasma aldosterone levels and its associated parameters
The parameters associated with plasma aldosterone levels were examined. Simple regression analysis showed that age, plasma levels of Alb, K, predialysis creatinine, UA, TG, and fasting insulin, and the HOMA-IR levels were significantly correlated with plasma aldosterone levels ( Table 4) . Multiple regression analysis was performed using these parameters, excluding TG, fasting insulin, and HbA1c, because these parameters were strongly correlated with the HOMA-IR. We found that the HOMA-IR was independently associated with plasma aldosterone levels ( Table 5) . Aldosterone levels were also associated with RWT by echocardiogram and with the ED ratio in carotid artery ultrasound (Fig. 1) .
HOMA-IR and associated parameters
The parameters associated with HOMA-IR were examined. Simple regression analysis showed that age, sex, history of diabetes, BMI, history of dyslipidemia, and plasma levels of ChE, HDL-C, TG, TP, UA, iP, and aldosterone were correlated with the HOMA-IR. The HOMA-IR was also correlated with the platelet count, Hb, and the WBC. The HOMA-IR was associated with pre-and postdialysis creatinine levels, post-dialysis BUN levels, Values are mean AE SE. ABI, ankle-brachial index; baPWV, brachial-ankle pulse wave velocity; ED ratio, end-diastolic velocity ratio; IMT, intima-media thickness. and Kt/V (Table 6 ). We performed multiple regression analysis using these associated parameters with the exclusion of a past history of diabetes and dyslipidemia, and plasma levels of HDL-C and TG. We found that that age, sex, BMI, and plasma levels of UA and aldosterone were independently associated with the HOMA-IR ( Table 7) . The association between efficacy of dialysis and insulin resistance showed that insulin resistance was related to a uremic state in patients on hemodialysis. This analysis also showed a close correlation between insulin resistance and plasma aldosterone levels. The relationship between HOMA-IR and various cardiovascular function parameters showed that the HOMA-IR was associated with IVST and PWT in echocardiography (Fig. 2) .
Cumulative effects of plasma aldosterone levels and the HOMA-IR on cardiovascular parameters
Activation of MR and insulin resistance contribute to pathogenesis of cardiovascular events, and these two pathogenic conditions are associated with each other (2, 10, 11) . Therefore, the combination of high levels of aldosterone and those of HOMA-IR might enhance cardiovascular tissue damage. We identified the patients group with this abnormality as HH group as described in Materials and Methods and found that the HH group had a lower EF, higher IVST and higher RWT compared with the LL group as defined in Materials and Methods (Fig. 3) .
Effects of diabetic condition on plasma aldosterone levels and insulin resistance in hemodialysis patients
Our cohort comprises 38% of diabetic patients. We analyzed the plasma aldosterone levels and insulin resistance in non-diabetic and diabetic The following parameters were excluded in the analysis; Triglyceride, fasting insulin, HbA1c. HOMA-IR, homeostasis model of insulin resistance. n/a, not applicable.
FIG. 1.
Echocardiographic and carotid artery ultrasound parameters related to aldosterone levels. Each graph represents linear regression analysis of plasma aldosterone levels and various parameters as shown by echocardiogram and carotid artery ultrasound (baPWV and ABI). r 2 and P-values are shown in each graph.
P < 0.05 was determined as significant and only significant relations are indicated.
patients individually (Table 1) . HOMA-IR levels were 1.37 in non-diabetic patients and 1.95 in diabetic patients, the difference of which was small but statistically significant (P = 0.039). We also investigated the factors associated with HOMA-IR level as shown in Table 6 and found that dialysis clearance factors including Kt/V, Pre-creat, Post-creat, and Pre BUN levels were associated with HOMA-IR in non-diabetic patients but not in diabetic patients. As for the relationship between aldosterone and HOMA-IR, we found that this relationship was detected both in diabetic patients and in nondiabetic patients. However, the association was more stringent in diabetic patients (r 2 = 0.372, P < 0.0001) than in non-diabetic patients (r 2 = 0.063, P = 0.044) ( Table 8) . .
DISCUSSION
In this study, we examined the clinical characteristics and relevance of plasma aldosterone levels and insulin resistance in patients on maintenance HD. Several important relationships were identified among these parameters. Our findings demonstrated that activation of the MR pathway and insulin resistance are interrelated and that each as well as in combination plays a role in cardiovascular tissue damages. The following parameters were excluded in the analysis; a past history of diabetes, a past history of dyslipidemia, HbA1c levels, high-density lipoprotein cholesterol, triglyceride. Aldosterone is a mineralocorticoid hormone that activates MR, leading to tissue damage by several potential mechanisms, including tissue inflammation and fibrosis (17) . Our study showed an association between cardiac hypertrophy and aldosterone, irrespective of blood pressure levels. Previous studies showed that plasma aldosterone levels were related to heart failure or cardiomegaly (17) . Additionally, MR blockade reduces cardiovascular and cerebrovascular morbidity and mortality (4) . In patients on HD, it was reported that plasma aldosterone levels are related to cardiovascular events (18) . Therefore, it is surmised that MR blockade have a favorable effect also on HD patients. Aldosterone also has various vascular effects, including endothelial dysfunction, vascular fibrosis, and arteriolar vasoconstriction. Our study showed that aldosterone levels were associated with the ED ratio in carotid artery ultrasound, which indicated carotid artery stenosis. This result is consistent with a recent report in nondiabetic patients on HD which showed that administration of an aldosterone blocker resulted in a significant decrease or even reversal of carotid IMT (19) . Although IMT levels were not correlated with plasma aldosterone levels in the present study, our data suggested some roles of aldosterone in the pathogenesis of cerebrovascular disease. Our study also showed that aldosterone has some effects on glucose and lipid metabolism. A close association between plasma aldosterone levels and insulin resistance has been reported in various pathogenic conditions, including primary aldosteronism, obesity, hypertension and CKD (11) . One of the mechanisms leading to glucose intolerance in excess aldosterone levels is potassium depletion, which could modulate pancreatic insulin secretion and insulin receptor function. Aldosterone also exerts direct effects on insulin receptor signaling. In our previous study, aldosterone blocked insulin signaling through an increase in ADMA levels, a decrease in nitric oxide production, and inactivation of Phosphoinositide-dependent protein kinase (PDK) in insulin signaling in adipose tissue (11, 20) . In the present study, the effects of aldosterone on insulin resistance consistently resulted in a rise in TG levels. Therefore, aldosterone plays a major role in systemic glucose and lipid metabolism in patients on HD. And we also found that this relationship was more close in diabetic patients (r 2 = 0.372, P < 0.0001) than in non-diabetic patients (r 2 = 0.063, P = 0.044). Therefore, the effects of aldosterone on insulin resistance in diabetic patients have influences dominantly the results of all the patients. Intervention of this association could provide a novel therapeutic strategy for nutritional disadvantages especially in diabetic patients on HD.
We also focused on insulin resistance in patients on HD and found that some metabolic parameters, including a history of diabetes and dyslipidemia, BMI, and plasma levels of HDL-C and TG, were related to the HOMA-IR. These findings are similar to the condition in metabolic syndrome where insulin resistance is considered to be the underlying pathological background, suggesting a role of adipose tissue in the pathogenesis of insulin resistance also in patients on HD. We also found that some anthropometric and nutritional parameters, including height, dry weight, and plasma levels of ChE, TP, and creatinine before and after hemodialysis, were positively associated with the HOMA-IR. Since plasma creatinine levels sometimes indicate muscle mass in patients on HD (21), these findings indicated that nutritional affluence, rather than a state of malnutrition or protein energy wasting state, determined insulin resistance or glucose and lipid metabolism in patients in this cohort. A recent study also showed the increased prevalence of metabolic syndrome in patients on HD (22) . In the current status of patients with sufficient dialysis and good nutrition, over-nutrition could become a future problem in terms of cardiovascular risk in patients on HD. In addition to these nutrition factors, dialysis clearance factors including Kt/V, Pre-creat, Postcreat, and Pre BUN levels were associated with HOMA-IR in non-diabetic patients but not in diabetic patients ( Table 6 ), indicating that insulin resistance is induced by the impairment of toxin clearance, and renal insulin resistance is more prominent in non-diabetic patients.
Despite the profound metabolic effect of insulin resistance, the clinical significance of insulin resistance in HD patients has not been fully established. In normal subjects, insulin resistance is responsible for cardiac hypertrophy and atherosclerosis. In patients on HD, insulin resistance is an independent risk factor for left ventricular hypertrophy (23) and associated with carotid arterial stiffness in nondiabetic HD patients (24) . Observational studies have shown that patients on HD with a higher insulin resistance have a higher risk of cardiovascular events compared with those with a lower insulin resistance (25) . The present study also showed that in HD patients the HOMA-IR was associated with IVST and PWT, which are clinical parameters for cardiac hypertrophy.
Our data showed that both plasma aldosterone levels and HOMA-IR levels were associated with echocardiographic parameters for cardiac hypertrophy, although each has different clinical significance. While plasma aldosterone levels were associated with RWT, HOMA-IR levels were with IVST and PWT. Previous study reported that high value of RWT indicated concentric hypertrophic remodeling, while the high value of LVMI indicated eccentric hypertrophy (26) . Our additional analysis revealed that close association was observed both between IVST and LVMI (r 2 = 0.352, P < 0.0001) and between PWT and LVMI (r 2 = 0.421, P < 0.0001), suggesting both IVST and PWT were also related to eccentric cardiac hypertrophy. Therefore, our data suggested that in HD patients, aldosterone might be associated with concentric cardiac hypertrophy and that insulin resistance with eccentric cardiac hypertrophy. The detailed mechanism for these different roles of humoral factors in cardiac remodeling remains to be explored.
In this analysis, most of the atherosclerotic parameters including IMT or PWV were not associated with aldosterone levels or HOMA-IR. These indexes may not be useful in the hemodialysis patients for 9.3 years on the average whose vascular lesions were mainly Monckeberg's sclerosis, also known as medial calcific sclerosis. To assess this lesion, we also measured calcified tissue score of the aorta, although neither aldosterone nor HOMA-IR was associated with this score, indicating this both humoral factors might not contribute to the medial calcific sclerosis.
There are several limitations in this study. One limitation is that the present study was a crosssectional study and it could not define causal relationships. Another limitation is that our study only focused on one dialysis facility and the number of patients was small. We obtained blood specimens on the first day of the week and we cannot exclude the effects of body fluid levels and various functional examinations on different days. However, our findings revealed a novel aspect of cardiovascular damage in patients on HD. Currently, a clinical trial is being performed to examine the effects of aldosterone blockade in HD patients. Our study provides the theoretical background for cardiovascular benefits by inhibition of MR.
CONCLUSIONS
In patients on maintenance hemodialysis, plasma aldosterone levels and insulin resistance are closely interrelated, each of which is associated with cardiovascular tissue damage. The constellation of increased aldosterone levels and insulin resistance is related to cardiovascular tissue damages.
